Reirradiation with Stereotactic Body Radiation Therapy for Spinal Metastases: Planning Procedure from a High-Volume Multi-Disciplinary Spine Oncology Program (SOaR2)

This journal activity provides practitioners with the knowledge needed to identify indications and technical details of reirradiation of metastatic disease of the spine.

This activity is available from May 6, 2026, through 11:59 p.m. Eastern time on May 5, 2028.

Perilesional Edema as a Predictor of Local Failure in Metastatic Brain Lesions Treated with Stereotactic Radiosurgery: A Systematic Review and Meta-Analysis

This educational activity dives into a review article examining the value of pre-treatment perilesional edema (PLE) as a prognostic factor for local failure after the treatment of brain metastases with stereotactic radiosurgery (SRS).

Contouring for Glioblastoma

Glioblastoma (GBM) patients with leptomeningeal disease (LMD) are a subgroup of GBM patients with distinctly poor prognosis. That being said, treatment options should be considered based on different clinical factors.

Gray Zone - Too Hot To Handle? Navigating the Dilemma of Radiation Necrosis after SRS for Brain Metastases

The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.

ASTRO/SNO Joint Activity: Current Multidisciplinary Management of Molecularly Defined IDH Mutant Grade 2 - 3 Glioma - Who, What, When, Why and How?

The management of patients with grade 2 – 3 glioma has recently become even more complicated due to incorporation of molecular findings for pathologic diagnosis, changing criteria for who is considered high risk, and variability in the use and choice of chemotherapy with radiotherapy.

Integrating Radiation Therapy with Novel Immunotherapies in the Management of Brain Metastases and Leptomeningeal Disease

With improved systemic therapy, the management of brain metastasis has become increasingly important. A number of immunotherapies and targeted agents have shown blood brain barrier penetration with a potential role in the upfront management of brain metastases and leptomeningeal disease.

Gray Zone - Nerve Wracking: Approaches to Locally Advanced Skull Base Adenoid Cystic Carcinoma with Extensive Perineural Spread

The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.

Potential Value of 68Ga-DOTATATE PET for Skull Base Meningioma Radiation Treatment Planning

This activity provides practitioners with the knowledge to use Dotatate PET for meningioma RT targeting.

This activity is available from January 8, 2026, through 11:59 p.m. Eastern time on January 7, 2028.

Palliative Radiation Therapy for Spine Metastases

This presentation focuses on the management of spine metastases with palliative radiation, emphasizing a multidisciplinary and patient-centered approach incorporating up-to-date clinical practice guidelines and evidence.

eContouring for Glioblastoma Webinar

GBM patients with LMD are a subgroup of GBM patients with distinctly poor prognosis. That being said, treatment options should be considered based on different clinical factors. In this eContouring webinar, we review how to approach these treatment options in a patient-by-patient basis.

Pages

Subscribe to RSS - Central Nervous System